Advocacy

142 YEARS OF EFFECTIVE ADVOCACY

CPA is the primary voice for Connecticut’s pharmacy profession in both Hartford and Washington DC — representing pharmacists in all practice settings, in all corners of the state.

Our legislative affairs team–including the CEO, Legislative Affairs Committee, lobbyists, and individual members–plays an active and crucial role in representing the pharmacy profession before the Commission of Pharmacy, the State Legislature, the Governor, and in the Courts. With constant changes occurring in health care policy, you need someone advocating on your behalf. Every year, dozens of bills are introduced in the state legislature that have an impact on pharmacy practice. Advocacy includes the monitoring of these issues as they develop, attending legislative meetings, testifying at legislative public hearings on the impact of proposed bills, as well as deploying grassroots lobbying and outreach to the state legislators by our members.

CPA Legislative Committee

The Legislative Committee is the driving force behind CPA’s public policy initiatives. Chaired by three Board Directors, the Legislative Committee is open to all CPA members in good standing. Click here to join the Legislative Committee.

CPA Political Action Committee

CPA members help advocate for the future of pharmacy through support of the CPA Political Action Committee. CPA-PAC’s purpose is to elect candidates who understand and support CPA’s mission of promoting health of the public through pharmacy practice. Click here to contribute to CPA-PAC.

CPA 2019 Legislative Agenda

Connecticut Pharmacy Day

CPA’s annual Pharmacy Day brings hundreds of pharmacists, pharmacy students, and supporters to the State Capitol for a day of one-on-one meetings with legislators, agencies, and offices. Pharmacy Day takes place in March of each year.

Key Pharmacy Policy Issues

Pharmacy policy and practice is influenced by an enormous number stakeholders and regulators. Just a few of the issues that CPA monitors closely include:

  • Pharmacist Provider Status
  • Reimbursement for Clinical Services
  • Influence of Health Bland & PBMs on Pharmacy Practice
  • Healthcare Reform
  • CURES and Prescription Drug Abuse
  • Workplace Regulations
  • Compounding
  • Medical Marijuana
  • Connecticut State Budget
  • Pharmacists’ Professional Liability
  • Collaborative Practice Agreements
  • Statewide Protocols
(L-R) Mary Keating, Phil Hritcko, Angelo DeFazio, U.S. Senator Chris Murphy, Rick Carbray,
Marghie Giuliano and Jean Keating after a briefing session on pharmacy issues in Senator Murphy’s Capitol offices